Harvard Health Experts and Contributors

Daniela J. Lamas, MD

Contributor

Daniela Lamas is a pulmonary and critical care doctor at the Brigham & Women’s Hospital and faculty at Harvard Medical School. Following graduation from Harvard College, she went on to earn her MD at Columbia University College of Physicians & Surgeons, where she also completed internship and residency. She then returned to Boston for her subspecialty fellowship. She has worked as a medical reporter at the Miami Herald and is frequently published in the New York Times. This is her first book.

Adam Landman, MD, MS, MIS, MHS

Contributor

Adam Landman, MD, MS, MIS, MHS is Chief Information Officer at Brigham Health, Associate Professor of Emergency Medicine at Harvard Medical School, and an attending emergency physician at Brigham and Women’s Hospital. He is board certified in Emergency Medicine and Clinical Informatics and an expert in health information technology and digital health design, development, and implementation. In his current role, he is responsible for developing strategic IT initiatives, with the goal of evolving the next generation of information systems and digital health solutions across the Brigham Health enterprise, while maintaining a focus on excellence.

Adaira I. Landry, MD, MEd

Contributor

Dr. Adaira Landry is an emergency medicine physician at Brigham and Women's Hospital in Boston, and an assistant professor at Harvard Medical School. She is a Harvard Medical School Society advisor, where she advises a cohort of medical students, and a co-chair for the diversity and inclusion committee for the department of emergency medicine at Brigham and Women’s Hospital. She is also a mother to three young children.

Helene Langevin, MD

Contributor

Dr. Langevin received an MD degree from McGill University, completed a post doctoral research fellowship in Neurochemistry at the MRC Neurochemical Pharmacology Unit in Cambridge, England, residency in Internal Medicine and fellowship in Endocrinology and Metabolism at Johns Hopkins Hospital. She is a Professor in Residence of Medicine and Director of the Osher Center for Integrative Medicine at Harvard Medical School and Brigham and Women’s Hospital. She is also a Visiting Professor of Neurological Sciences at the University of Vermont College of Medicine. Dr. Langevin has been the Principal Investigator of several NIH-funded studies investigating the role of connective tissue in low back pain and the mechanisms of acupuncture, manual and movement-based therapies. Her previous studies in humans and animal models have shown that mechanical tissue stimulation during both tissue stretch and acupuncture causes dynamic cellular responses in connective tissue. Her current work focuses on the effects of stretching on inflammation resolution mechanisms within connective tissue, and their relevance to chronic musculoskeletal pain and cancer.

Debi LaPlante, PhD

Contributor

Dr. Debi LaPlante is director of the Division on Addiction at the Cambridge Health Alliance, and an assistant professor of psychiatry at Harvard Medical School. She joined the Division in 2001 and is involved with its diverse research, education, training, and outreach activities. With her colleagues, she developed the Syndrome Model of Addiction, and co-edited the two volume APA Addiction Syndrome Handbook. She has authored dozens of book chapters, journal articles, and reports. Dr. LaPlante authored the Harvard Health Publishing ebook Responsible Drinking for Women. Dr. LaPlante’s current research involves assessments of public health treatment and intervention systems, studies of actual gambling and daily fantasy sports behavior, and tribal participatory research to develop a culturally grounded, mental health first-response training program, xaʔtu̓s (Salish for First Face) for Mental Health. In addition to these activities, Dr. LaPlante is a member of the editorial team for the Division’s The Brief Addiction Science Information Source. She also has been a course director for online and live continuing education courses for addiction, and for gambling-related problems specifically. She is a regular reviewer for research grants and academic journal submissions. Dr. LaPlante spearheaded the Division’s Cambridge Health Alliance Readiness for Gambling Expansion initiative, which features Gambling Disorder Screening Day on the second Tuesday of March annually.

Nicole J. LeBlanc, MA

Contributor

Nicole J. LeBlanc is a doctoral candidate in clinical psychology at Harvard University, where she conducts research on the association between social factors and the development and maintenance of emotional disorders. She is also a clinical fellow in the department of psychology at Massachusetts General Hospital, where she is completing clinical and research training with the Cognitive Behavioral Therapy Program and the Center for Anxiety and Traumatic Stress Disorders. Her clinical interests include empirically-supported treatments for anxiety and traumatic stress disorders. She is a member of the Association for Behavioral and Cognitive Therapies (ABCT) and the Anxiety and Depression Association of America (ADAA).

Erica H. Lee, PhD

Contributor

Erica H. Lee, PhD, is a clinical psychologist and associate training director of the psychology internship program at Boston Children’s Hospital, as well as an instructor in psychology at Harvard Medical School. She specializes in evidence-based and culturally responsive care for youth with depression, anxiety, disruptive behavior, and traumatic stress. Dr. Lee also teaches on these topics nationally and internationally, and engages in research on increasing access to mental health care.

Dara K. Lee Lewis, MD

Contributor

Dara Lee Lewis, MD, is a full-time cardiologist, director of imaging, and co-director of the Women’s Program at the Lown Cardiovascular Center. Her clinical interests include cardiac physiology, echocardiography, and heart disease in women. She is an associate physician at Brigham and Women’s Hospital. She also co-directs, teaches, and develops curriculum for the first-year Harvard Medical School cardiology, physiology, and pathophysiology course. Dr. Lee Lewis earned her medical degree from Harvard Medical School and completed her residency in internal medicine and fellowship in cardiology at Brigham and Women’s Hospital.

Anthony Lembo, MD

Contributor

Anthony Lembo, MD, is Director of the GI Motility and Functional Bowel Disorders Program at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School in Boston, MA. Dr. Lembo earned his medical degree from Tufts University School of Medicine in Boston and completed his residency in medicine, as well as fellowships in gastroenterology and gastrointestinal motility and irritable bowel syndrome (IBS), at the University of California, Los Angeles, (UCLA) Medical Center. Dr. Lembo’s research interests focus on the burden of and treatment options for irritable bowel syndrome (IBS) and chronic constipation, and he also studies the placebo response. He has published widely on these topics, He is also an Associate Editor of the Journal of Clinical Gastroenterology and Digestive Diseases and Science. He also been appointed numerous national and international leadership positions throughout his tenure.

Inga Lennes, MD, MPH, MBA

Contributor

Inga T. Lennes MD, MPH, MBA grew up in the midwest and came to the east coast for college. She attended Mount Holyoke College for her undergraduate degree and went on to attend the University of Massachusetts Medical School for her medical degree. Dr. Lennes completed her internal medicine residency training at Beth Israel Deaconess Medical Center and also was a Chief Medical Resident at BIDMC. She trained as a Hematology and Oncology Fellow in the Dana Farber/Mass General Brigham Cancer Care Fellowship. Dr. Lennes is a medical oncologist in the Center for Thoracic Cancers and specializes in seeing all lung cancers and esophageal cancer. She is the founder and director of the Pulmonary Nodule Clinic at Massachusetts General Hospital and works closely with colleagues to study and implement lung cancer screening and improve nodule management. Dr. Lennes is the Massachusetts General Physicians Organization Senior Vice President for Service Excellence and Practice Improvement.

Maureen Leonard, MD, MMSc

Contributor

Maureen Leonard, MD, MMSc, is the Clinical Director of the Center For Celiac Research And Treatment at MassGeneral Hospital for Children (MGHfC) and an Assistant Professor of Pediatrics at Harvard Medical School (HMS). She sees adult and pediatric patients with celiac disease, non-celiac gluten sensitivity, and other gluten-related disorders. Dr. Leonard obtained her medical degree from New York Medical College, completed her residency in general pediatrics at Tufts Medical Center and completed her fellowship in Pediatric Gastroenterology at MGHf C. Dr. Leonard received a Master’s Degree in Clinical and Translational Investigation from HMS. Dr. Leonard’s research is focused on predicting and preventing celiac disease through the NIH-funded Celiac Disease; Genomic, Environment, Microbiome and Metabolomic Study. Dr. Leonard’s other work include identifying biomarkers that can predict intestinal healing in pediatric patients with celiac disease, building translational models capable of predicting autoimmune disease in high risk individuals, and working with industry collaborators to create and perform clinical trials aimed at treating celiac disease. Dr. Leonard currently holds funding from the NIH (K23DK122127) and has previously been funded by the NIH (F32DK109620), Nutrition Obesity Research Center at Harvard, and the Thrasher Research Foundation.

Sharon Levy, MD, MPH

Contributor

Sharon Levy, MD, MPH is a board certified Developmental-Behavioral Pediatrician and an Associate Professor of Pediatrics at Harvard Medical School. She is the Director of the Adolescent Substance use and Addiction Program (ASAP) in the Division of Developmental Medicine at Boston Children’s Hospital, which is comprised of clinical, research, training and policy arms. Dr. Levy has evaluated and treated thousands of adolescents with substance use disorders, and has taught national curricula and published extensively on the outpatient management of substance use disorders in adolescents, including screening and brief advice in primary care, the use of drug testing and the outpatient management of opioid dependent adolescents. She is the past chair of the American Academy of Pediatrics Committee on Substance Use and Prevention, the President of the Association for Medical Education and Research in Substance Abuse (AMERSA) and serves on the board of directors of the Addiction Medicine Fellowship Director’s Association.

Howard E. LeWine, MD

Chief Medical Editor, Harvard Health Publishing

Howard LeWine, M.D., is a practicing internist at Brigham and Women’s Hospital in Boston, Chief Medical Editor at Harvard Health Publishing, and editor in chief of Harvard Men’s Health Watch.

Annie Lewis-O'Connor, PhD, NP-BC, MPH, FAAN

Contributor

Dr. Annie Lewis-O’Connor is a dually board certified (pediatrics and women’s health) nurse practitioner. She is the founder and director of the C.A.R.E. Clinic (Coordinated Approach to Resiliency & Empowerment) at Brigham and Women’s Hospital, Boston, MA; an associate scientist in the division of women’s health/department of medicine at BWH; and an instructor at Harvard Medical School. Dr. Lewis-O’Connor addresses violence from four pillars: research, policy, education, and clinical practice. Currently, she is a clinical scholar with the Robert Wood Johnson Foundation (2018–2021). Since 2012, she has served as co-chair of the Mass General Brigham Trauma-Informed Care Initiative. She received her master’s in nursing from Simmons College in Boston, a master’s in public health from Boston University, and her PhD from Boston College.

Elizabeth Liebson, MD

Contributor

Elizabeth Liebson, MD, is a staff psychiatrist on the Schizophrenia and Bipolar Disorders Unit at Mclean Hospital and assistant professor at Harvard Medical School. She divides her time between clinical work and teaching residents and medical students. Dr. Liebson’s clinical focus is assessment of first psychotic episodes and exploring patients’ subjective experiences. Dr. Liebson has been on staff at McLean Hospital since 2006. While primarily a clinician, Dr. Liebson has experience as an investigator in several disciplines relevant to clinical neuroscience research, including nosology and clinical pharmacology.

John Sanford Limouze, MD

Contributor

Dr. John Limouze is associate chief of the Division of Hospitalist Medicine at Cambridge Health Alliance, a lecturer in Medicine at Harvard Medical School and a Master’s Student at Harvard’s Center for Bioethics. He is a graduate of the University of Pennsylvania School of Medicine and completed residency training in internal medicine at the University of Michigan. His academic interests include medical professionalism, conscience, and providing care to vulnerable populations.

Jennifer Lin, MD

Contributor

Jennifer Lin, MD, co-directs the Melanoma Risk and Prevention Clinic, and the Multicultural Dermatology clinic at Brigham and Women’s Hospital. She also is the Dermatology Lead of the Melanoma Program at Dana Farber Cancer Institute. She has authored several papers related to melanoma as well as on lasers and light-based therapies. Dr. Lin received her medical degree from Harvard Medical School. She completed her residency at the Harvard Residency Program, and completed her fellowship at Massachusetts General Hospital.

Kristina Liu, MD, MHS

Contributor

Kristina Liu, MD, MHS, is a dermatologist at Brigham and Women’s Hospital, where she serves as the director of the vitiligo clinic and director of dermatology simulation education. She received her medical degree and masters in health science from Yale School of Medicine, and completed her residency at the Harvard Combined Dermatology Program, where she served as chief resident. Her clinical and research interests include laser and cosmetic dermatology, pigmentary disorders of the skin, and medical education.

Victor A. Lopez-Carmen, MPH

Guest Contributor

Victor A. Lopez-Carmen, MPH, is a Dakota and Yaqui writer, health advocate, and student at Harvard Medical School. He is currently a member of Boston’s COVID-19 Health Inequities Task Force, and cochair of the UN Global Indigenous Youth Caucus. His commentary on minority health has been featured in the BBC, The Boston Globe, Teen Vogue, and the UN News Centre.

Kevin R. Loughlin, MD, MBA

Contributor

Kevin R. Loughlin, MD, MBA, received an AB from Princeton University, MD from New York Medical College, MBA from Boston University, and MA (honorary) from Harvard University. He practiced urology at Brigham and Women’s Hospital for 35 years, receiving an AUA research award while in training. He received the Alumni Medal of Honor from New York Medical College, the Lifetime Achievement Award from the New England Section of the AUA, and the Distinguished Service Award from the American Urological Association. He received the faculty teaching award on three occasions. He was a trustee of the American Board of Urology and a member of the board of directors of the American Urological Association. He has published over 250 articles in the medical literature, has been an author or editor of 12 books, and has served on multiple medical journal editorial boards.

Recent Blog Articles

Harvard Health Experts and Contributors

List of Experts

Daniela J. Lamas, MD

Adam Landman, MD, MS, MIS, MHS

Adaira I. Landry, MD, MEd

Helene Langevin, MD

Debi LaPlante, PhD

Nicole J. LeBlanc, MA

Erica H. Lee, PhD

Dara K. Lee Lewis, MD

Anthony Lembo, MD

Inga Lennes, MD, MPH, MBA

Maureen Leonard, MD, MMSc

Sharon Levy, MD, MPH

Howard E. LeWine, MD

Annie Lewis-O'Connor, PhD, NP-BC, MPH, FAAN

Elizabeth Liebson, MD

John Sanford Limouze, MD

Jennifer Lin, MD

Kristina Liu, MD, MHS

Victor A. Lopez-Carmen, MPH

Kevin R. Loughlin, MD, MBA